Fig. 8.
Fig. 8. BO2C11 inhibits fVIIIa. Plasma-derived fVIII (5 IU/mL; 1 μg/mL) was incubated with bovine thrombin (0.1 U/mL) for 30 seconds at 37°C, and the reaction was stopped by the addition of hirudin. fVIIIa was then mixed for 90 seconds at 37°C with factor IXa, factor X, PL, and CaCl2, in the absence or presence of different concentrations of BO2C11. The final concentration of fVIII in the assay was 1 IU/mL (200 ng/mL). After 90 seconds, the generation of factor Xa was evaluated by the addition of a chromogenic substrate for a further 5 minutes of incubation. OD was read at 405 nm and results were expressed as percentages of OD measured in the absence of BO2C11.

BO2C11 inhibits fVIIIa. Plasma-derived fVIII (5 IU/mL; 1 μg/mL) was incubated with bovine thrombin (0.1 U/mL) for 30 seconds at 37°C, and the reaction was stopped by the addition of hirudin. fVIIIa was then mixed for 90 seconds at 37°C with factor IXa, factor X, PL, and CaCl2, in the absence or presence of different concentrations of BO2C11. The final concentration of fVIII in the assay was 1 IU/mL (200 ng/mL). After 90 seconds, the generation of factor Xa was evaluated by the addition of a chromogenic substrate for a further 5 minutes of incubation. OD was read at 405 nm and results were expressed as percentages of OD measured in the absence of BO2C11.

Close Modal

or Create an Account

Close Modal
Close Modal